Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: Implications for health-care utilization in Australia
2012 ◽
Vol 9
(3)
◽
pp. 239-248
◽
Keyword(s):
2016 ◽
Vol 8
(4)
◽
pp. 355-358
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 44
(17)
◽
pp. 2615-2622
◽
2015 ◽
Vol 66
(14)
◽
pp. 1566-1574
◽
Keyword(s):
2019 ◽
Vol 56
◽
pp. 004695801989690
Keyword(s):
Race and Colorectal Cancer Disparities: Health-Care Utilization vs Different Cancer Susceptibilities
2010 ◽
Vol 102
(8)
◽
pp. 538-546
◽
Keyword(s):